|
1
|
|
|
2
|
- State:
- … Any medical event equivalent to CTC Grade 3, 4, 5 which precipitated
hospitalization (or prolongation of existing hospitalization) must be
reported regardless of
requirements for Phase of study, expected or unexpected and
attribution.
- CTEP Home Page: http://ctep.info.nih.gov
- NCI GUIDELINES: EXPEDITED ADVERSE EVENT REPORTING
- REQUIREMENTS FOR NCI
INVESTIGATIONAL AGENTS
- Section 3, Table C1
- January 2001
|
|
3
|
- Any adverse drug experience occurring at any dose that results
- in any of the following outcomes:
- Death
- A life-threatening adverse drug experience
- Inpatient hospitalization or prolongation of existing hospitalization
- A persistent or significant disability/incapacity;
- A congenital anomaly/birth defect.
- Important medical events that may not result in death, be life
- threatening, or require hospitalization may be considered an SAE
- drug experience, when, based upon medical judgment, they may
- jeopardize the patient and may require medical or surgical
- intervention to prevent one of the outcomes listed in the definition.
|
|
4
|
- RTOG SAE Safety Reporting Requirements
- All SAEs that fall under any one of the categories outlined in the
previous SAE definition must
- be reported via telephone to RTOG Data Management 215-717-2762 within 24
hours of
- discovery of the event. The Data Manager taking the call will inform the
caller which type of
- report (5 or 10 day AdEERS) is required for the event. The required
report must be submitted
- electronically within the required timeframe from the initial phone
report to allow RTOG to
- comply with the reporting requirements of pharmaceutical sponsors. All
supporting source
- documentation must be faxed to the RTOG dedicated SAE fax line
[215-717-0990] as soon
- as available.
- In addition, AML/MDS diagnosis requires a 30 day timeframe for reporting
using Secondary
- AML/MDS Form available on NCI Website
- SAE reporting is safety related separate from and in addition to data
management toxicity reporting requirements.
|
|
5
|
- Proper identification of follow-up or amended reports, supporting
source documentation and/or other relevant information is imperative and
must always include RTOG study
and case number
|
|
6
|
- 215-717-0990
- All necessary supporting source documentation noted as being
- supplied in the Additional Information Section of the AdEERS
- Report should be properly labeled with the RTOG Study and Case
- Number as well as the date of the corresponding event and provided
within the allotted timeframe or as soon as it becomes available via the
RTOG SAE Dedicated Fax Line at 215-717-0990.
|
|
7
|
|
|
8
|
- The time frame for submitting the required type of report will vary from
FIVE to TEN CALENDAR DAYS according to the expectedness and relationship
of the event.
- The day the event is called in to RTOG HQ is counted as day 1.
- The reporting deadline is required to allow pharmaceutical sponsors to
fulfill their external regulatory reporting obligations.
|